Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
J Fungi (Basel) ; 9(6)2023 May 31.
Article in English | MEDLINE | ID: mdl-37367572

ABSTRACT

Candidiasis, caused mainly by Candida albicans, a natural commensal of the human digestive tract and vagina, is the most common opportunistic fungal infection at the mucosal and systemic levels. Its high morbi-mortality rates have led to considerable research to identify the molecular mechanisms associated with the switch to pathogenic development and to diagnose this process as accurately as possible. Since the 1980s, the advent of monoclonal antibody (mAb) technology has led to significant progress in both interrelated fields. This linear review, intended to be didactic, was prompted by considering how, over several decades, a single mAb designated 5B2 contributed to the elucidation of the molecular mechanisms of pathogenesis based on ß-1,2-linked oligomannoside expression in Candida species. These contributions starting from the structural identification of the minimal epitope as a di-mannoside from the ß-1,2 series consisted then in the demonstration that it was shared by a large number of cell wall proteins differently anchored in the cell wall and the discovery of a cell wall glycoplipid shed by the yeast in contact of host cells, the phospholipomannan. Cytological analysis revealed an overall highly complex epitope expression at the cell surface concerning all growth phases and a patchy distribution resulting from the merging of cytoplasmic vesicles to plasmalema and further secretion through cell wall channels. On the host side, the mAb 5B2 led to identification of Galectin-3 as the human receptor dedicated to ß-mannosides and signal transduction pathways leading to cytokine secretion directing host immune responses. Clinical applications concerned in vivo imaging of Candida infectious foci, direct examination of clinical samples and detection of circulating serum antigens that complement the Platelia Ag test for an increased sensitivity of diagnosis. Finally, the most interesting character of mAb 5B2 is probably its ability to reveal C. albicans pathogenic behaviour in reacting specifically with vaginal secretions from women infected versus colonized by this species as well as to display higher reactivity with strains isolated in pathogenic circumstances or even linked to an unfavourable prognosis for systemic candidiasis. Together with a detailed referenced description of these studies, the review provides a complementary reading frame by listing the wide range of technologies involving mAb 5B2 over time, evidencing a practical robustness and versatility unique so far in the Candida field. Finally, the basic and clinical perspectives opened up by these studies are briefly discussed with regard to prospects for future applications of mAb 5B2 in current research challenges.

2.
Clin Infect Dis ; 77(5): 711-720, 2023 09 11.
Article in English | MEDLINE | ID: mdl-37132362

ABSTRACT

BACKGROUND: Except for cryptococcosis, fungal infection of the central nervous system (FI-CNS) is a rare but severe complication. Clinical and radiological signs are non-specific, and the value of conventional mycological diagnosis is very low. This study aimed to assess the value of ß1,3-D-glucan (BDG) detection in the cerebrospinal fluid (CSF) of non-neonatal non-cryptococcosis patients. METHODS: Cases associated with BDG assay in the CSF performed in 3 French University Hospitals over 5 years were included. Clinical, radiological, and mycological results were used to classify the episodes as proven/highly probable, probable, excluded, and unclassified FI-CNS. Sensitivity and specificity were compared to that calculated from an exhaustive review of the literature. RESULTS: In total, 228 episodes consisting of 4, 7, 177, and 40 proven/highly probable, probable, excluded, and unclassified FI-CNS, respectively, were analysed. The sensitivity of BDG assay in CSF to diagnose proven/highly probable/probable FI-CNS ranged from 72.7% [95% confidence interval {CI}: 43.4%‒90.2%] to 100% [95% CI: 51%‒100%] in our study and was 82% in the literature. For the first time, specificity could be calculated over a large panel of pertinent controls and was found at 81.8% [95% CI: 75.3%‒86.8%]. Bacterial neurologic infections were associated with several false positive results. CONCLUSIONS: Despite its sub-optimal performance, BDG assay in the CSF should be added to the diagnostic armamentarium for FI-CNS.


Subject(s)
Cryptococcosis , beta-Glucans , Humans , Glucans , Retrospective Studies , Sensitivity and Specificity , Cryptococcosis/diagnosis , Central Nervous System , Multicenter Studies as Topic
3.
Eur J Clin Microbiol Infect Dis ; 42(6): 781-786, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37060382

ABSTRACT

Toxocariasis is a cosmopolitan helminthiasis linked to contamination with Toxocara cati or Toxocara canis. Only six isolated cases of pleural toxocariasis have been reported in the literature. We describe a case of pleurisy with isolated eosinophilia varying between 600 and 1500/mm3 likely linked o presumptive toxocariasis in a 72-year-old patient. Our patient was admitted to hospital with severe dyspnoea, asthenia and diarrhoea. Imaging studies confirmed right unilateral pleurisy without any parenchymal involvement. Serology of serum and pleural fluid was positive for anti-Toxocara antibodies by ELISA and immunoblotting. Treatment by pleural drainage and anti-parasitic medication with albendazole for 8 days resulted in the resolution of symptoms. A decrease in the levels of polynuclear eosinophils and total IgE confirmed the clinical resolution. The presence of hypereosinophilia in pleural fluid should evoke a diagnosis of pleural toxocariasis. Clinical symptoms and imaging are non-specific, but positive serology for anti-Toxocara antibodies in serum and pleural fluid can confirm the diagnosis.


Subject(s)
Eosinophilia , Pleurisy , Toxocariasis , Animals , Humans , Aged , Toxocariasis/diagnosis , Toxocariasis/drug therapy , Toxocara , Albendazole/therapeutic use , Enzyme-Linked Immunosorbent Assay , Eosinophilia/diagnosis , Eosinophilia/drug therapy , Pleurisy/drug therapy
4.
Pathogens ; 11(6)2022 Jun 17.
Article in English | MEDLINE | ID: mdl-35745553

ABSTRACT

Cryptococcosis is the third most common cause of invasive fungal infection in solid organ transplant recipients and cryptococcal meningitis (CM) its main clinical presentation. CM outcomes, as well as its clinical features and radiological characteristics, have not yet been considered on a large scale in the context of kidney transplantation (KT). We performed a nationwide retrospective study of adult patients diagnosed with cryptococcosis after KT between 2002 and 2020 across 30 clinical centers in France. We sought to describe overall and graft survival based on whether KT patients with cryptococcosis developed CM or not. Clinical indicators of CNS involvement and brain radiological characteristics were assessed. Eighty-eight cases of cryptococcosis were diagnosed during the study period, with 61 (69.3%) cases of CM. Mortality was high (32.8%) at 12 months (M12) but not significantly different whether or not patients presented with CM. Baseline hyponatremia and at least one neurological symptom were independently associated with CM (p < 0.001). Positive serum cryptococcal antigen at diagnosis was also significantly associated with CM (p < 0.001). On magnetic resonance imaging (MRI), three patterns of brain injury were identified: parenchymal, meningeal, and vascular lesions. Although CM does not affect graft function directly, it entails a grim prognosis.

5.
J Fungi (Basel) ; 7(5)2021 Apr 22.
Article in English | MEDLINE | ID: mdl-33922391

ABSTRACT

BACKGROUND AND AIMS: This study prompted by growing evidence of the relationship between the yeast Candida albicans and Crohn's disease (CD) was intended to assess the effect of a 6-month course of the antifungal fluconazole (FCZ) on post-operative recurrence of CD. METHODS: Mycological samples (mouth swabs and stools) and serum samples were collected from 28 CD patients randomized to receive either FCZ (n = 14) or placebo (n = 14) before surgical resection. Serological analysis focused on levels of calprotectin, anti-glycan antibodies, and antibody markers of C. albicans pathogenic transition. Levels of galectin-3 and mannose binding lectin (MBL) involved in C. albicans sensing and inflammation were also measured. RESULTS: 1, 2, 3, and 6 months after surgery, endoscopy revealed recurrence in 5/12 (41.7%) patients in the FCZ group and 5/9 (55.6%) in the placebo group, the small cohort preventing any clinical conclusions. In both groups, surgery was followed by a marked decrease in C. albicans colonization and biomarkers of C. albicans pathogenic transition decreased to non-significant levels. Anti-glycan antibodies also decreased but remained significant for CD. Galectin-3 and calprotectin also decreased. Conversely, MBL levels, which inversely correlated with anti-C. albicans antibodies before surgery, remained stable. Building biostatistical multivariate models to analyze he changes in antibody and lectin levels revealed a significant relationship between C. albicans and CD. CONCLUSION: Several combinations of biomarkers of adaptive and innate immunity targeting C. albicans were predictive of CD recurrence after surgery, with area under the curves (AUCs) as high as 0.86. FCZ had a positive effect on biomarkers evolution. ClinicalTrials.gov ID: NCT02997059, 19 December 2016. University Hospital Lille, Ministry of Health, France. Effect of Fluconazole on the Levels of Anti-Saccharomyces cerevisiae Antibodies (ASCA) After Surgical Resection for Crohn's Disease. Multicenter, Randomized, and Controlled in Two Parallel Groups Versus Placebo.

6.
Transpl Infect Dis ; 22(5): e13313, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32386273

ABSTRACT

A 65-year-old man was diagnosed with an invasive Aspergillus fumigatus infection with sternal osteomyelitis 4 months after heart transplantation. Unfortunately, after 8 weeks patient developed severe cutaneous and neurological toxicities induced by voriconazole leading to drug discontinuation. Therefore, isavuconazole was chosen as second-line therapy. The patient presented a favorable outcome and tolerance was excellent after ten months monotherapy. Here, we report for a first time, an successful isavuconazole-based treatment of sternal osteomyelitis aspergillosis in a cardiac recipient.


Subject(s)
Heart Transplantation , Nitriles/therapeutic use , Osteomyelitis , Pyridines/therapeutic use , Triazoles/therapeutic use , Aged , Antifungal Agents/therapeutic use , Aspergillus fumigatus , Humans , Male , Osteomyelitis/drug therapy , Voriconazole
7.
J Med Chem ; 63(5): 2074-2094, 2020 03 12.
Article in English | MEDLINE | ID: mdl-31525963

ABSTRACT

This report deals with the design, the synthesis, and the pharmacological evaluation of pyroglutamide-based P2X7 antagonists. A dozen were shown to possess improved properties, among which inhibition of YO-PRO-1/TO-PRO-3 uptake and IL1ß release upon BzATP activation of the receptor and dampening signs of DSS-induced colitis on mice, in comparison with reference antagonist GSK1370319A. Docking study and biological evaluation of synthesized compounds has highlighted new SAR, and low toxicity profiles of pyroglutamides herein described are clues for the finding of a usable h-P2X7 antagonist drug. Such a drug would raise the hope for a cure to many P2X7-dependent pathologies, including inflammatory, neurological, and immune diseases.


Subject(s)
Drug Delivery Systems/methods , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/metabolism , Purinergic P2X Receptor Antagonists/administration & dosage , Purinergic P2X Receptor Antagonists/metabolism , Receptors, Purinergic P2X7/metabolism , Animals , Cell Survival/drug effects , Cell Survival/physiology , Dextran Sulfate/toxicity , Female , HEK293 Cells , Humans , Inflammatory Bowel Diseases/chemically induced , Mice , Mice, Inbred C57BL
8.
Travel Med Infect Dis ; 35: 101509, 2020.
Article in English | MEDLINE | ID: mdl-31712179

ABSTRACT

BACKGROUND: Toxoplasmosis is a zoonosis caused by the protozoan Toxoplasma gondii. In immunocompetent patients the infection is usually benign. However, cases of severe and even lethal primo-infections are regularly reported in South America. In contrast, data from tropical Africa are fragmentary. METHODS: Data for French cases of severe toxoplasmosis acquired between 2013 and 2018, in tropical Africa and among immunocompetent patients were collected retrospectively in 2018. RESULTS: Four male patients with a mean age of 34-years were identified. All infections originated in West or Central Africa. The clinical presentations were heterogeneous: two patients had severe disseminated toxoplasmosis, of which one presented with chorioretinitis associated with myositis and the other with febrile pneumopathy; one patient presented with post-infectious acute cerebellar ataxia and the final case had general symptoms and skin manifestations. The diagnosis of acute toxoplasmosis was confirmed by serology in four patients. Molecular diagnosis confirmed T. gondii infection in three patients with Africa 1 as the dominant genotype. The infection was cured with anti-infective treatment in all four patients. Ocular sequelae were reported in the two patients with chorioretinitis. CONCLUSIONS: Imported cases of severe toxoplasmosis in immunocompetent patients are rare in France. However, this aetiology should be evoked rapidly in a patient with a severe infectious syndrome who has recently visited or originated from tropical Africa.


Subject(s)
Toxoplasma/isolation & purification , Toxoplasmosis/complications , Toxoplasmosis/epidemiology , Adult , Africa South of the Sahara/epidemiology , Cerebellar Ataxia/etiology , Chorioretinitis/etiology , Communicable Diseases, Imported , France/epidemiology , Humans , Immunocompetence , Male , Myositis/etiology , Toxoplasma/genetics , Toxoplasmosis/drug therapy
9.
Article in English | MEDLINE | ID: mdl-31781518

ABSTRACT

Platelets play an important role in the innate immune response. During candidaemia, circulating fungal polysaccharides, including chitin, are released into the bloodstream and can interact with platelets and induce modulation of platelet activities. However, the role of circulating chitin in platelet modulation has not been investigated. The aims of the present study were to assess the effect of fungal chitin on activation, adhesion, aggregation and receptor expression of platelets and their impact on the host defense against Candida albicans. Platelets pre-treated with different concentrations of chitin (10-400 µg/mL) extracted from C. albicans were analyzed in terms of activation, Toll-like receptor (TLR) expression, aggregation and adhesion to C. albicans. Chitin treatment reduced platelet adhesion to C. albicans and neutrophils. P-selectin expression was significantly decreased in platelets challenged with chitin. Aggregation and intracellular Ca2+ influx were also decreased in platelets. TLR8 mRNA and proteins were expressed in platelets pre-treated with chitin when compared to untreated platelets. Overall, chitin purified from C. albicans reduced the adhesion, activation and aggregation of platelets mediated via TLR8 stimulation by decreasing intracellular Ca2+ influx and P-selectin expression.


Subject(s)
Blood Platelets/immunology , Blood Platelets/metabolism , Chitin/immunology , Fungal Polysaccharides/immunology , Platelet Activation , Toll-Like Receptor 8/metabolism , Biomarkers , Calcium/metabolism , Candida albicans/physiology , Candidiasis/immunology , Candidiasis/metabolism , Candidiasis/microbiology , Cell Adhesion , Cell Communication , Gene Expression , Humans , Neutrophils/immunology , Neutrophils/metabolism , Platelet Activation/immunology , Platelet Adhesiveness/immunology , Toll-Like Receptor 8/agonists
10.
Front Microbiol ; 10: 469, 2019.
Article in English | MEDLINE | ID: mdl-30941108

ABSTRACT

Invasive fungal infections are some of the most life-threatening infectious diseases in the hospital setting. In industrialized countries, the most common fungal species isolated from immunocompromised patients are Candida and Aspergillus spp. However, the number of infections due to Mucorales spp. is constantly increasing and little is known about the virulence factors of these fungi. The fungal cell wall is an important structure protecting fungi from the environment. A better knowledge of its composition should improve our understanding of host-pathogen interactions. Cell wall molecules are involved in tissue adherence, immune escape strategies, and stimulation of host defenses including phagocytosis and mediators of humoral immunity. The fungal cell wall is also a target of choice for the development of diagnostic or therapeutic tools. The present review discusses our current knowledge on the cell wall structure of Mucorales in terms of the polysaccharides and glyco-enzymes involved in its biosynthesis and degradation, with an emphasis on the missing gaps in our knowledge.

11.
Am J Trop Med Hyg ; 99(1): 94-96, 2018 07.
Article in English | MEDLINE | ID: mdl-29714164

ABSTRACT

Schistosomiasis due to Schistosoma haematobium is a widespread disease usually affecting the urinary tract associated with hematuria and kidney disorders. Neurological damage is rarely reported and symptoms are nonspecific and may suggest brain tumors such as glioma. We describe the first double ectopic haematobium schistosomiasis case involving the brain and intestine.


Subject(s)
Brain Neoplasms/diagnostic imaging , Brain/parasitology , Glioblastoma/diagnostic imaging , Schistosoma haematobium/drug effects , Schistosomiasis haematobia/parasitology , Animals , Anthelmintics/therapeutic use , Brain/diagnostic imaging , Brain/pathology , Brain Neoplasms/pathology , Congo , Diagnosis, Differential , France , Glioblastoma/pathology , Humans , Intestines/parasitology , Intestines/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Praziquantel/therapeutic use , Schistosoma haematobium/pathogenicity , Schistosoma haematobium/physiology , Schistosomiasis haematobia/diagnostic imaging , Schistosomiasis haematobia/drug therapy , Travel
12.
Am J Trop Med Hyg ; 99(1): 90-93, 2018 07.
Article in English | MEDLINE | ID: mdl-29692301

ABSTRACT

Microsporidia are protists close to the kingdom of fungi that may cause eye infections. Most cases are reported in Asia and affect both immunocompromised and immunocompetent patients. Here, we report a rare case of microsporidial keratoconjunctivitis in an immunocompetent French patient 3 weeks after returning from India. In our patient, Weber trichrome staining of conjunctival scrapings revealed rounded elements approximately 1-3 µm in size. Conventional polymerase chain reaction analysis by ribosomal RNA subunit sequencing showed 100% identity with Vittaforma corneae. Treatment by corneal debridement combined with fluoroquinolone eye drops allowed complete resolution of the lesions. Although rare, ocular microsporidiosis should be investigated in a patient who is native to Asia or has returned from an endemic area and presents with keratoconjunctivitis of undetermined etiology.


Subject(s)
Antifungal Agents/therapeutic use , Eye Infections, Fungal/diagnosis , Fluoroquinolones/therapeutic use , Keratoconjunctivitis/diagnosis , Microsporidiosis/diagnosis , Cornea/drug effects , Cornea/microbiology , Cornea/pathology , Cornea/surgery , Debridement/methods , Eye Infections, Fungal/drug therapy , Eye Infections, Fungal/microbiology , Eye Infections, Fungal/surgery , France , Humans , India , Keratoconjunctivitis/drug therapy , Keratoconjunctivitis/microbiology , Keratoconjunctivitis/surgery , Male , Microsporidiosis/drug therapy , Microsporidiosis/microbiology , Microsporidiosis/surgery , Middle Aged , Travel , Vittaforma/drug effects , Vittaforma/growth & development , Vittaforma/pathogenicity
13.
BMC Ophthalmol ; 18(1): 88, 2018 Apr 10.
Article in English | MEDLINE | ID: mdl-29631556

ABSTRACT

BACKGROUND: Clostridium perfringens is an uncommon pathogen in endophthalmitis, causing rapid destruction of ocular tissues. Clostridium perfringens infection typically occurs after penetrating injury with soil-contaminated foreign bodies. CASE REPORT: Here, we describe the case of a 17-year-old male who sustained a penetrating injury with a metallic intraocular foreign body and who rapidly developed severe C. perfringens panophthalmitis with orbital cellulitis. He was managed by systemic and intravitreal antibiotics, resulting in preservation of the globe, but a poor visual outcome. CONCLUSION: Clostridial endophthalmitis secondary to penetrating injuries is a fulminant infection, almost always resulting in loss of the globe in the case of advanced infection. When feasible, early vitrectomy and intravitreal antibiotics should be considered in patients with penetrating eye injuries with contaminated foreign bodies.


Subject(s)
Clostridium Infections/microbiology , Clostridium perfringens/isolation & purification , Eye Infections, Bacterial/complications , Orbital Cellulitis/microbiology , Adolescent , Eye Foreign Bodies/complications , Eye Injuries, Penetrating/complications , Humans , Male
14.
Travel Med Infect Dis ; 20: 26-30, 2017.
Article in English | MEDLINE | ID: mdl-29050898

ABSTRACT

We describe a case of imported cutaneous gnathostomiasis in a Thai patient living in France. Gnathostomiasis is a zoonosis of food origin. The disease is endemic in Southeast Asia and Latin America. However, over the past 30 years, an increasing number of imported cases has been described in Europe and America. The disease is rare in Western Europe and the majority of cases described had a cutaneous clinical presentation. The disease may sometimes be confused with allergy, leading to a delay in diagnosis. Visceral symptoms are rare but may follow severe attacks. A definitive diagnosis can be obtained by the isolation of larvae from skin biopsies, but these are rarely performed. The diagnosis is usually presumptive, based on a combination of anamnestic, clinical, and biological factors. Several courses of the anti-helminths, albendazole or ivermectin, are often necessary. Although rare, the diagnosis should be evoked systematically in a migrant or traveller returning from an endemic area with cutaneous lesions.


Subject(s)
Gnathostoma , Gnathostomiasis/diagnosis , Gnathostomiasis/drug therapy , Ivermectin/therapeutic use , Travel-Related Illness , Adult , Animals , Antiparasitic Agents/therapeutic use , Female , Food Parasitology , France , Gnathostomiasis/epidemiology , Gnathostomiasis/transmission , Humans , Skin/parasitology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...